SunTrust Banks set a $58.00 target price on Encompass Health (AMEX:EHC) in a research report released on Thursday, December 21st. The firm currently has a buy rating on the stock.
Other research analysts also recently issued research reports about the company. Stephens assumed coverage on Encompass Health in a research note on Thursday, August 31st. They set an overweight rating and a $53.00 price target for the company. William Blair reissued an outperform rating on shares of Encompass Health in a report on Tuesday, November 21st. Robert W. Baird reissued a buy rating and set a $55.00 price objective on shares of Encompass Health in a report on Monday, October 9th. Piper Jaffray Companies reissued a hold rating and set a $50.00 price objective on shares of Encompass Health in a report on Sunday, September 17th. Finally, KeyCorp reissued a hold rating on shares of Encompass Health in a report on Thursday, September 7th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the stock. Encompass Health has a consensus rating of Hold and a consensus price target of $53.11.
Encompass Health (AMEX:EHC) opened at $51.46 on Thursday. The stock has a market capitalization of $4,960.00, a price-to-earnings ratio of 18.78, a price-to-earnings-growth ratio of 1.70 and a beta of 0.54. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34. Encompass Health has a 12 month low of $38.24 and a 12 month high of $52.58.
Encompass Health (AMEX:EHC) last announced its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. The firm had revenue of $995.60 million during the quarter, compared to the consensus estimate of $985.75 million. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.65 EPS. equities research analysts expect that Encompass Health will post 2.72 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 annualized dividend and a dividend yield of 1.94%. Encompass Health’s dividend payout ratio (DPR) is presently 36.50%.
In other news, Director Yvonne M. Curl acquired 1,000 shares of Encompass Health stock in a transaction dated Wednesday, November 1st. The shares were purchased at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the transaction, the director now owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.
An institutional investor recently bought a new position in Encompass Health stock. Dalton Greiner Hartman Maher & Co. acquired a new stake in shares of Encompass Health Corp (AMEX:EHC) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 331,823 shares of the company’s stock, valued at approximately $16,395,000. Dalton Greiner Hartman Maher & Co. owned about 0.34% of Encompass Health at the end of the most recent quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “SunTrust Banks Analysts Give Encompass Health (EHC) a $58.00 Price Target” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/01/13/healthsouth-hls-receives-buy-rating-from-suntrust-banks.html.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.